Promoter length polymorphism in UGT1A1 and the risk of sporadic colorectal cancer

Cancer Genetics

Volumn 205, Issue 4, 2012, Pages 163-167

  Hiljadnikova Bajro, Marija ^a   Josifovski, Toni ^b   Panovski, Milco ^b   Jankulovski, Nikola ^b   Kapedanovska Nestorovska, Aleksandra ^a   Matevska, Nadica ^a   Petrusevska, Natalija ^b   Dimovski, Aleksandar J ^a  

^a SS Cyril and Methodius University Faculty of Pharmacy   (Macedonia)

^b SS CYRIL AND METHODIUS UNIVERSITY OF SKOPJE   (Macedonia)

Author keywords

Colorectal cancer; Polymorphism; Risk; UGT1A1

Indexed keywords

GLUCURONOSYLTRANSFERASE 1A1; BILIRUBIN URIDINE DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; BILIRUBIN URIDINE-DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE;

ADULT; ALLELE; ARTICLE; CANCER RISK; CARCINOGENESIS; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; TUMOR GENE; UGT1A1 GENE; WILD TYPE; AGED; COLORECTAL TUMOR; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; GREECE; MIDDLE AGED; RISK FACTOR;

AGED; AGED, 80 AND OVER; ALLELES; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUCURONOSYLTRANSFERASE; GREECE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 84862747006     PISSN: 22107762     EISSN: 22107770     Source Type: Journal    
DOI: 10.1016/j.cancergen.2012.01.015     Document Type: Article

References (32)

1. Ferlay J, Shin HR, Bray F, et al. GLOBOCAN 2008 v1.2, Cancer incidence and mortality worldwide: IARC CancerBase No. 10. Available at: Accessed on September 15, 2011. http://globocan.iarc.fr.
2. Garcia M., Jemal A., Ward E.M., et al. Global cancer facts and figures 2007 2007, American Cancer Society, Atlanta, GA.
3. Potter J.D. Colorectal cancer: molecules and populations. J Natl Cancer Inst 1999, 91(11):916-932.
4. Tukey R.H., Strassburg C.P. Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 2000, 40:581-616.
5. Jansen P.L., Mulder G.J., Burchell B., et al. New developments in glucuronidation research: report of a workshop on " glucuronidation, its role in health and disease" Hepatology 1992, 15(3):532-544.
6. Ito N., Hasegawa R., Sano M., et al. A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine(PhIP). Carcinogenesis 1991, 12(8):1503-1506.
7. Shirai T., Sano M., Tamano S., et al. The prostate: a target for carcinogenicity of 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine (PhIP) derived from cooked foods. Cancer Res 1997, 57(2):195-198.
8. Zheng W., Gustafson D.R., Sinha R., et al. Well-done meat intake and the risk of breast cancer. J Natl Cancer Inst 1998, 90(22):1724-1729.
9. Mireles L.C., Lum M.A., Dennery P.A. Antioxidant and cytotoxic effects of bilirubin on neonatal erythrocytes. Pediatr Res 1999, 45(3):355-362.
10. Stocker R., Yamamoto Y., McDonagh A.F., et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987, 235(4792):1043-1046.
11. Bosma P.J., Chowdhury J.R., Bakker C., et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med 1995, 333(18). 1171-115.
12. Raijmakers M.T., Jansen P.L., Steegers E.A., et al. Association of human liver bilirubin UDP-glucuronyltransferase activity with a polymorphism in the promoter region of the UGT1A1 gene. J Hepatol 2000, 33(3):348-351.
13. Guillemette C., Millikan R., Newman B., et al. Genetic polymorphisms in UGT1A1 and association with breast cancer among African Americans. Cancer Res 2000, 60(4):950-956.
14. Adegoke O.J., Shu X.O., Gao Y.T., et al. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer. Breast Cancer Res Treat 2004, 85(3):239-245.
15. Guillemette C., De Vivo I., Hankinson S.E., et al. Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels. Cancer Epidemiol Biomarkers Prev 2001, 10(6):711-714.
16. Tsezou A., Tzetis M., Giannatou E., et al. Genetic polymorphisms in the UGT1A1 gene and breast cancer risk in Greek women. Genet Test 2007, 11(3):303-306.
17. Huo D., Kim H.J., Adebamowo C.A., et al. Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and breast cancer risk in Africans. Breast Cancer Res Treat 2008, 110(2):367-376.
18. Cecchin E., Russo A., Corona G., et al. UGT1A1*28 polymorphism in ovarian cancer patients. Oncol Rep 2004, 12(2):457-462.
19. Sambrook J., Fritsch E.F., Maniatis T. Molecular cloning: a laboratory manual 1989, Cold Spring Harbor Laboratory Press, New York, NY. 2nd ed.
20. Sinha R., Rothman N. Role of well-done, grilled red meat, heterocyclic amines (HCAs) in the etiology of human cancer. Cancer Lett 1999, 143(2):189-194.
21. Malfatti M.A., Wu R.W., Felton J.S. The effect of UDP-glucuronosyltransferase 1A1 expression on the mutagenicity and metabolism of the cooked-food carcinogen 2-amino-1-methyl-6-phenylimidazo [4,5-b]pyridine in CHO cells. Mutat Res 2005, 570(2):205-214.
22. Ko W.F., Helzlsouer K.J., Comstock G.W. Serum albumin, bilirubin, and uric acid and the anatomic site-specific incidence of colon cancer. J Natl Cancer Inst 1994, 86(24):1874-1875.
23. Girard H., Butler L.M., Villeneuve L., et al. UGT1A1 and UGT1A9 functional variants meat intake, and colon cancer, among Caucasians andAfrican-Americans. Mutat Res 2008, 644(1-2):56-63.
24. van der Logt E.M., Bergevoet S.M., Roelofs H.M., et al. Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis 2004, 25(12):2407-2415.
25. Tang K.S., Chiu H.F., Chen H.H., et al. Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase 1A7 and 1A1 genes. World J Gastroenterol 2005, 11(21):3250-3254.
26. Calle E.E., Miracle-McMahill H.L., Thun M.J., Heath C.W. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst 1995, 87(7):517-523.
27. Newcomb P.A., Zheng Y., Chia V.M., et al. Estrogen plus progestin use, microsatellite instability, and the risk of colorectal cancer in women. Cancer Res 2007, 67(15):7534-7539.
28. Slattery M.L., Anderson K., Samowitz W., et al. Hormone replacement therapy and improved survival among postmenopausal women diagnosed with colon cancer (USA). Cancer Causes Control 1999, 10(5):467-473.
29. Guillemette C. Pharmacogenomics of human UDP-glucuronosyltransferase enzymes. Pharmacogenomics J 2003, 3(3):136-158.
30. Stram D.O., Liu Y., Henderson K.D., et al. Age-specific effects of hormone therapy use on overall mortality and ischemic heart disease mortality among women in the California Teachers Study. Menopause 2011, (3):253-261.
31. Salpeter S.R., Cheng J., Thabane L., et al. Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women. Am J Med 2009, 122(11):1016-1022.
32. Cheung A.M. Review: hormone therapy reduces mortality in younger postmenopausal women. Ann Intern Med 2010, 152(8):JC4-JC9.